About us
Anagnostics: Leading the Future of Molecular Diagnostics
At Anagnostics, we are dedicated to pioneering advancements in molecular diagnostics. By providing innovative solutions for both research and clinical diagnostics, we are reshaping the way diseases are detected, analyzed, and understood. Our expertise lies in developing cutting-edge diagnostic tools that empower healthcare professionals, researchers, and scientists worldwide to improve patient care, optimize outcomes, and drive scientific discovery.
Our Commitment to Innovation
At Anagnostics, we are constantly innovating to meet the evolving needs of the molecular diagnostics field. Our focus on user satisfaction and scientific advancement drives us to deliver high-quality diagnostic solutions. We aim to enhance healthcare by providing professionals with tools that enable better decision-making and improve patient outcomes.
Meet our experts
Dedicated professionals driving our success
Tony Fred, Chief Executive Officer
As the visionary behind Anagnostics, Tony is dedicated to advancing biotechnology solutions. His passion for solving real-world problems through biotechnology guides the company's growth and success.
Mich Stark, Chief Commercial Officer
With years of experience in the biotechnology industry, Mich has played a pivotal role in driving Anagnostics’ success. His leadership is instrumental in expanding our reach and impact in the molecular diagnostics space.
Dr. Aline Turner, Chief Technical Officer
Dr. Turner leads our technical team, advancing the development of cutting-edge biotechnological solutions. Her expertise ensures that Anagnostics remains at the forefront of innovation in diagnostics.
Iris Joe, Chief Financial Officer
Iris plays a critical role in Anagnostics’ financial strategy. Her expertise in managing complex funding landscapes drives the company's sustainable growth and financial stability.